increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by nobody – 2017-06-08 19:16 (2954 d 02:19 ago) – Posting: # 17462
Views: 15,392

Hi Dr!

To me: That's not how it works with generics. Go for equivalent dissolution and therefore Cmax/AUC. End of story.

Why go for "better" solubility and end up non-BE? ;-) Don't see the point at all.

You could go for some hybrid application in Europe (regulatory is not my piece of cake), but good luck with explaining the "advantage" of your product to the authority(ies) :-D
—
Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,677 registered users;
66 visitors (0 registered, 66 guests [including 13 identified bots]).
Forum time: 21:36 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5